Tag - CGNSF

Developments

Cognetivity, Ketamine One collaborating on depression, PTSD studies

Cognetivity Neurosciences (CSE:CGN; OTCQB:CGNSF; FWB:1UB) entered a collaborative partnership with Ketamine One Capital to study and develop assessments for depression and post-traumatic stress disorder (PTSD). In the...

December 7, 2021

Developments

Cognetivity Neurosciences presents new results at AD conference

Cognetivity Neurosciences (CSE:CGN; OTCQB:CGNSF; FWB:1UB) presented significant new results demonstrating the capabilities of its Integrated Cognitive Assessment (ICA) platform at the Clinical Trials on Alzheimer’s...

November 9, 2021

Developments

Cognetivity Neurosciences to place ICA system in Dubai

Cognetivity Neurosciences (CSE:CGN; OTCQB:CGNSF; FWB:1UB) reached its first commercial agreement for the Integrated Cognitive Assessment (ICA) to be deployed at the Clemenceau Medical Center (CMC) in Dubai. CMC is...

September 22, 2021

Developments

Cognetivity’s ICA to be deployed in world-leading UK dementia care practice

Cognetivity Neurosciences (CSE:CGN; OTCQB:CGNSF) agreed with Loveday & Co. to deploy the Integrated Cognitive Assessment (ICA) in the specialist dementia and senior care provider’s practice. Loveday is the only...

September 14, 2021

Developments

Cognetivity ICA test to be deployed in new NHS brain clinic in UK

Cognetivity Neurosciences’ (CSE:CGN; OTCQB:CGNSF) Integrated Cognitive Assessment (ICA) test is to form an integral part of a new and highly innovative clinic in the UK’s National Health Service (NHS) dedicated to...

July 15, 2021

Tag - CGNSF

Cognetivity, Ketamine One collaborating on depression, PTSD studies

Cognetivity Neurosciences presents new results at AD conference

Cognetivity Neurosciences to place ICA system in Dubai

Cognetivity’s ICA to be deployed in world-leading UK dementia care practice

Cognetivity ICA test to be deployed in new NHS brain clinic in UK

General

More